FDA to hold discussion on safety of stem cell testing

WASHINGTON The Food and Drug Administration has scheduled a special public session on April 10 to discuss the safety concerns of testing embryonic stem cells in humans, according to Bloomberg.

In that regard, Geron and Advanced Cell Technology have plans this year to begin the first human test of therapies created with stem cells extracted from human embryos. They agency is asking the companies to monitor whether the therapies can cause non-cancerous growths, as has been seen in animal tests.